Categoría: News
-
New Stem Cells Identified for Regenerating Liver Tissue
The discovery of a protein marker leads to the isolation of liver stem cells.
-
Business is Booming as Pfizer Targets the Aging Processs With New Adult Stem Cell Research
As yet another indication of the economic maturation of an industry, the pharmaceutical giant Pfizer is now developing anti-aging stem cell products.
-
An Adult Stem Cell Company Wins Award for Innovation
The biotech company Mesoblast Ltd., specializing in regenerative medicine, is awarded a prestigious award for its adult stem cell technology.
-
Brain Tissue Formed From Monkey Teeth Stem Cells
Researchers at Emory University have successfully generated several types of neural cells from the dental pulp of monkeys.
-
Therapeutic Immune Response Identified From Cancer Stem Cells
Scientists propose a new type of cancer therapy based upon an immunological response to a specific type of cancer stem cell.
-
FDA Grants Clearance for the First Clinical Study With Placental Stem Cells
Celgene Cellular Therapeutics receives FDA authorization to commence the first clinical trials ever to be conducted in the U.S. with adult stem cells derived from placental blood.
-
Opexa to Present Data on its Cellular Therapies for Autoimmune Diseases
Opexa Therapeutics is scheduled to present an overview of its T-cell and adult stem cell therapies for autoimmune diseases at an annual health care conference.
-
Genzyme and Osiris Form Adult Stem Cell Mega-Partnership
In one of the largest business arrangements ever made, Osiris and Genzyme agree upon a major adult stem cell collaboration.
-
New Study Demonstrates Important Role of Endogenous Stem Cells in Angiogenesis
Researchers in Japan demonstrate that adult stem cells derived from adipose tissue stimulate angiogenesis through the mobilization of endogenous bone marrow stem cells.
-
Adult Stem Cell Company to Begin Clinical Trials for Critical Limb Ischemia
Harvest Technologies has received FDA authorization to commence the first clinical trials with autologous adult stem cells in the treatment of critical limb ischemia.